RxDoctor Payments Data

Stephen Schroeder, DPM

Podiatrist · Tigard, ORNPI 1083658926

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (28.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Arthrex at 45.5% of the total. Reporting peaked in 2019 at $14,987 and has fallen 89.0% since, to $1,650 in 2025. Among podiatrist clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,597in general payments, 2019–2025

Across 169 payments — averaging $163.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$13K
  • Acumed LLC$6K
  • Steelhead Surgical Inc$3K
  • Exactech, Inc.$2K
  • Paragon 28, Inc.$1K
  • Stryker$1K
  • plus $1K from 13 others
$140,000in ownership & investment interests, 2019–2025

Across 7 payments — averaging $20,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$140K

What the payments were for

  • Consulting fees$5,80121%
  • Speaking & faculty fees$6,00022%
  • Travel & lodging$7,83428%
  • Food & beverage$7,43427%
  • Education$5292%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,597 in reported general payments places this provider in the 95th percentile of 74 podiatrist providers in Oregon.

See all podiatrist providers in Oregon

Medicare billing

Part B allowed, 2024
$84,479
Medicare patients
132
Services billed
1,435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen47$496
Celecoxib11$87

Paid to pharmacies, not to this prescriber.

Other podiatrist in Tigard

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →